Technical performance evaluation of the MyT4 point of care technology for CD4+ T cell enumeration

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Mwau, Matilu ^a   Kadima, Silvia ^b   Mwende, Joy ^a   Adhiambo, Maureen ^a   Akinyi, Catherine ^a   Prescott, Marta ^b   Lusike, Judi ^b   Hungu, Jackson ^b   Vojnov, Lara ^b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b CLINTON HEALTH ACCESS INITIATIVE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CELL ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POINT OF CARE TESTING; PROCESS DEVELOPMENT; SENSITIVITY AND SPECIFICITY; BLOOD; CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; IMMUNOLOGY; KENYA; POINT OF CARE SYSTEM; PROCEDURES; REPRODUCIBILITY; STANDARDS;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; KENYA; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84907192021     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107410     Document Type: Article

References (17)

1. World Health Organization (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach.
2. Baker J, Peng G, Rapkin J., Abrams D, Silverberg M, et al (2008) CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 22: 841-848.
3. SMART Study Group, Emery S, Neuhaus JA, Phillips AN, Babiker A, et al. (2008) Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 197: 1133-1144.
4. O'Brien W.A., Hartigan PM, Martin D, Esinhart J., Hill A, et al. (1996) Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 334: 426-431.
5. Post FA, Wood R, Maartens G. (1996) CD4 and total lymphocyte counts as predictors of HIV disease progression. QJM 89: 505-508.
6. Hulgan T, Shepherd BE, Raffanti S.P., Fusco JS, Beckerman R, et al. (2007) Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy. J Infect Dis 195: 425-431.
7. Kagaayi J, Makumbi F, Nakigozi G., Wawer MJ, Gray RH, et al. (2007) WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. AIDS 21: 1208-1210.
8. Mermin J, Ekwaru J, Were W., Degerman R, Bunnell R, et al (2011) Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ 343: d6792-d6792.
9. UNAIDS (2011) Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/document/2011/06/20110610-un-a-res-65-277-en.pdf. Accessed 1 November 2012.
10. Jani IV, Sitoe NE, Alfai E.R., Chongo PL, Quevedo JI, et al. (2011) Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 378: 1572-1579.
11. Wynberg E, Cooke G, Shroufi A., Reid SD, Ford N. (2014) Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc 17: 18809.
12. UNITAID (2013) HIV/AIDS Diagnostic Technology Landscape, 3rd edition.
13. Glencross DK, Coetzee LM, Faal M, Masango M., Stevens WS, et al. (2012) Performance evaluation of the Pima point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc 15: 3.
14. Manabe Y, Wang Y, Elbireer A., Auerbach B, Castelnuovo B. (2012) Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral Therapy. PLoS ONE 7: e34319.
15. Mtapuri-Zinyowera S., Chideme M, Mangwanya D., Mugurungi O, Gudukeya S, et al (2010) Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr 55: 1-7.
16. Jani IV, Peter T.F. (2013) How point-of-care testing could drive innovation in global health. N Engl J Med 368: 2319-2324.
17. Mwau M, Adungo F, Kadima S., Njagi E, Kirwaye C, et al (2013) Evaluation of PIMA Point of Care Technology for CD4 T Cell Enumeration in Kenya. PLoS ONE 8: e67612.